18F-FDG PET/CT, 99mTc-MIBI, and MRI in the Prediction of Outcome of Patients With Multiple Myeloma: A Comparative Study.
Fonti R et al. Clin Nucl Med. 2015 Jan 20. [Epub ahead of print].

Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement.
Dimopoulos MA et al. J Clin Oncol. 2015 Jan 20. pii: JCO.2014.57.9961. [Epub ahead of print].

Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.
Mylin AK et al. Leuk Lymphoma. 2015 Jan 9:1-28. [Epub ahead of print].

Absolute Lymphocyte Count as Predictor of Overall survival for Patients with Multiple Myeloma Treated with Single Autologous Stem Cell Transplant.
Jimenez-Zepeda VH et al. Leuk Lymphoma. 2015 Jan 9:1-23. [Epub ahead of print].

Advances in the medical imaging of multiple myeloma and related clinical significance.
Zhang HB et al. 2014 Dec 30;36(6):671-4. doi: 10.3881/j.issn.1000-503X.2014.06.021.

Tumor-induced CD14+HLA-DR -/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
Wang Z et al. Cancer Immunol Immunother. 2014 Dec 30. [Epub ahead of print].

18F-FDG-PET Increases Visibility of Bone Lesions in Relapsed Multiple Myeloma: Is this Hypoxia Driven?
de Waal EG et al. Clin Nucl Med. 2014 Dec 26. [Epub ahead of print].

Association of QCT bone mineral density and bone structure with vertebral fractures in patients with multiple myeloma.
Borggrefe J et al. J Bone Miner Res. 2014 Dec 26. doi: 10.1002/jbmr.2443. [Epub ahead of print].

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era.
Takamatsu H et al. Cancer Sci. 2014 Dec 22. doi: 10.1111/cas.12594. [Epub ahead of print].

Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
Mihailovic J et al. Semin Nucl Med. 2015 Jan;45(1):16-31. doi: 10.1053/j.semnuclmed.2014.08.002.

Versican and its associated molecules: Potential diagnostic markers for multiple myeloma.
Gupta N et al. Clin Chim Acta. 2015 Jan 23. pii: S0009-8981(15)00026-1. doi: 10.1016/j.cca.2015.01.012. [Epub ahead of print].